Beyond the genome: Epigenetic mechanisms in lung remodeling

Physiology

Volumn 29, Issue 3, 2014, Pages 177-185

  Hagood, James S ^a  

^a RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; GENETIC EPIGENESIS; GENETICS; GENOME; HUMAN; LUNG; PHYSIOLOGY;

ANIMALS; EPIGENESIS, GENETIC; GENOME; HUMANS; LUNG;

EID: 84900826900     PISSN: 15489213     EISSN: 15489221     Source Type: Journal    
DOI: 10.1152/physiol.00048.2013     Document Type: Review

References (111)

1. Adcock IM, Ford P, Ito K, Barnes PJ. Epigenetics and airways disease. Respir Res 7: 21, 2006.
2. Akhtar S, Coward WR, Feghali-Bostwick CA, Jenkins G, Knox A, Pang L. Molecular mechanisms of increased expression of the chemokine monocyte chemoattractant. Protein-1 (mcp-1) in idiopathic pulmonary fibrosis (ipf). Am J Respir Crit Care Med 183: A3466, 2011.
3. Arand J, Spieler D, Karius T, Branco MR, Meilinger D, Meiss-ner A, Jenuwein T, Xu G, Leonhardt H, Wolf V, Walter J. In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases. PLos Genet 8: e1002750, 2012.
4. Archer SL, Marsboom G, Kim GH, Zhang HJ, Toth PT, Svens-son EC, Dyck JR, Gomberg-Maitland M, Thebaud B, Husain AN, Cipriani N, Rehman J. Epigenetic attenuation of mito-chondrial superoxide dismutase 2 in pulmonary arterial hypertension: a basis for excessive cell proliferation and a new therapeutic target. Circulation 121: 2661-2671, 2010.
5. Banerjee T, Chakravarti D. A peek into the complex realm of histone phosphorylation. Mol Cell Biol 31: 4858-4873, 2011.
6. Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol 131: 636-645, 2013.
7. Barnes PJ. Targeting the epigenome in the treatment of asthma and chronic obstructive pulmonary disease. Proc Am Thor Soc 6: 693-696, 2009.
8. Barreiro E, Sznajder JI. Epigenetic regulation of muscle phe-notype and adaptation: a potential role in COPD muscle dysfunction. J Appl Physiol 114: 1263-1272, 2013.
9. Bjornsson HT, Fallin MD, Feinberg AP. An integrated epige-netic and genetic approach to common human disease. Trends Genet 20: 350-358, 2004.
10. Black JC, Whetstine JR. Chromatin landscape: methylation beyond transcription. Epigenetics 6: 9-15, 2011.
11. Bolden JE, Shi W, Jankowski K, Kan CY, Cluse L, Martin BP, MacKenzie KL, Smyth GK, Johnstone RW. HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses. Cell Death Dis 4: e519, 2013.
12. Campos EI, Reinberg D. Histones: annotating chromatin. Annu Rev Genet 43: 559-599, 2009.
13. Cao Y, Vo T, Millien G, Tagne JB, Kotton D, Mason RJ, Williams MC, Ramirez MI. Epigenetic mechanisms modulate thyroid transcription factor 1-mediated transcription of the surfactant protein B gene. J Biol Chem 285: 2152-2164, 2010.
14. Carvalho RH, Haberle V, Hou J, van Gent T, Thongjuea S, van Ijcken W, Kockx C, Brouwer R, Rijkers E, Sieuwerts A, Foek-ens J, van Vroonhoven M, Aerts J, Grosveld F, Lenhard B, Philipsen S. Genome-wide DNA methylation profiling of non-small cell lung carcinomas. Epigenetics Chromatin 5: 9, 2012.
15. Chen C, Yin N, Yin B, Lu Q. DNA methylation in thoracic neoplasms. Cancer Lett 301: 7-16, 2011.
16. Cisneros J, Hagood J, Checa M, Ortiz-Quintero B, Negreros M, Herrera I, Ramos C, Pardo A, Selman M. Hypermethyla-tion-mediated silencing of p14(ARF) in fibroblasts from idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 303: L295-L303, 2012.
17. Costa FF. Non-coding RNAs: meet thy masters. Bioessays 32: 599-608, 2010.
18. Coward WR, Watts K, Feghali-Bostwick CA, Jenkins G, Pang L. Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis. Mol Cell Biol 30: 2874-2886, 2010.
19. Coward WR, Watts K, Feghali-Bostwick CA, Knox A, Pang L Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis. Mol Cell Biol 29: 4325-4339, 2009.
20. Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Than-nickal VJ, Cardoso WV, Lu J. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45: 287-294, 2011.
21. Dakhlallah D, Batte K, Wang Y, Cantemir-Stone CZ, Yan P, Nuovo G, Mikhail A, Hitchcock CL, Wright VP, Nana-Sinkam SP, Piper MG, Marsh CB. Epigenetic regulation of miR-17~92 contributes to the pathogenesis of pulmonary fibrosis. Am J Respir Crit Care Med 187: 397-405, 2013.
22. Davies ER, Haitchi HM, Thatcher TH, Sime PJ, Kottmann RM, Ganesan A, Packham G, O'Reilly KM, Davies DE. Spiruchos-tatin A inhibits proliferation and differentiation of fibroblasts from patients with pulmonary fibrosis. Am J Respir Cell Mol Biol 46: 687-694, 2012.
23. Davis S, Lollo B, Freier S, Esau C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res 34: 2294-2304, 2006.
24. Dekker FJ, Haisma HJ. Histone acetyl transferases as emerging drug targets. Drug Discov Today 14: 942-948, 2009.
25. Durham A, Chou PC, Kirkham P, Adcock IM. Epigenetics in asthma and other inflammatory lung diseases. Epigenomics 2: 523-537, 2010.
26. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473: 43-49, 2011.
27. Grant JS, White K, Maclean MR, Baker AH. MicroRNAs in pulmonary arterial remodeling. Cell Mol Life Sci 2013.
28. Guo W, Shan B, Klingsberg RC, Qin X, Lasky JA. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol 297: L864-L870, 2009.
29. Hamvas A, Deterding R, Balch WE, Schwartz DA, Albertine KH, Whitsett JA, Cardoso WV, Kotton DN, Kourembanas S, Hagood JS. Diffuse lung disease in children: summary of a scientific conference. Pediatr Pulmonol. In press.
30. Hargreaves DC, Crabtree GR. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res 21: 396-420, 2011.
31. Hatzimichael E, Crook T. Cancer epigenetics: new therapies and new challenges. J Drug Delivery 2013: 529312, 2013.
32. Herceg Z, Vaissiere T. Epigenetic mechanisms and cancer: an interface between the environment and the genome. Epigenetics 6: 804-819, 2011.
33. Ho AS, Turcan S, Chan TA. Epigenetic therapy: use of agents targeting deacetylation and methylation in cancer management. Onco Targets Ther 6: 223-232, 2013.
34. Hogaboam CM, Murray L, Martinez FJ. Epigenetic mechanisms through which Toll-like receptor-9 drives idiopathic pulmonary fibrosis progression. Proc Am ThoracSoc9: 172-176, 2012.
35. Hu B, Gharaee-Kermani M, Wu Z, Phan SH. Epi-genetic regulation of myofibroblast differentiation by DNA methylation. Am J Pathol 177: 21-28, 2010.
36. Hu B, Gharaee-Kermani M, Wu Z, Phan SH. Essential role of MeCP2 in the regulation of myofi-broblast differentiation during pulmonary fibrosis. Am J Pathol 178: 1500-1508, 2011.
37. Hu B, Wu Z, Hergert P, Henke CA, Bitterman PB, Phan SH. Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1. Am J Pathol 182: 71-83, 2013.
38. Huang K, Fan G. DNA methylation in cell differentiation and reprogramming: an emerging systematic view. Regen Med 5: 531-544, 2010.
39. Huang SK, Fisher AS, Scruggs AM, White ES, Hoga-boam CM, Richardson BC, Peters-Golden M. Hyper-methylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. Am J Pathol 177: 2245-2255, 2010.
40. Huang SK, Scruggs AM, Donaghy J, Horowitz JC, Zaslona Z, Przybranowski S, White ES, Peters-Golden M. Histone modifications are responsible for decreased Fas expression and apoptosis resistance in fibrotic lung fibroblasts. Cell Death Dis 4: e621, 2013.
41. Huang Y, Pastor WA, Shen Y, Tahiliani M, Liu DR, Rao A. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLos One 5: e8888, 2010.
42. Huopaniemi I, Suvitaival T, Nikkila J, Oresic M, Kaski S. Multivariate multi-way analysis of multi-source data. Bioinformatics 26: i391-i398, 2010.
43. Hyduke DR, Lewis NE, Palsson BO. Analysis of omics data with genome-scale models of metabolism. Mol Bio Sys 9: 167-174, 2013.
44. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Mon-tano C, Onyango P, Cui H, Gabo K, Rongione M, Webster M, Ji H, Potash JB, Sabunciyan S, Fein-berg AP. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nature Gen 41: 178-186, 2009.
45. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352: 1967-1976, 2005.
46. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S. Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23: 806-812, 2009.
47. Jordan R, Patel S, Hu H, Lyons-Weiler J. Efficiency analysis of competing tests for finding differentially expressed genes in lung adenocar-cinoma. Cancer Inform 6: 389-421, 2008.
48. Joss-Moore LA, Albertine KH, Lane RH. Epige-netics and the developmental origins of lung disease. Mol Genet Metab 104: 61-66, 2011.
49. Joss-Moore LA, Wang Y, Ogata EM, Sainz AJ, Yu X, Callaway CW, McKnight RA, Albertine KH, Lane RH. IUGR differentially alters MeCP2 expression and H3K9Me3 of the PPARgamma gene in male and female rat lungs during alveolariza-tion. Birth Defects Res A Clin Mol Teratol 91: 672-681, 2011.
50. Kabesch M, Adcock IM. Epigenetics in asthma and COPD. Biochimie 94: 2231-2241, 2012.
51. Karlic R, Chung HR, Lasserre J, Vlahovicek K, Vingron M. Histone modification levels are predictive for gene expression. Proc Natl Acad Sci USA 107: 2926-2931, 2010.
52. Karras JG, Sun G, Tay J, Jackson AL. Reflections on microRNAs in chronic pulmonary disease: looking into the miR-ror and crystal ball. Inflammation Allergy Drug Targets 12: 88-98, 2013.
53. Khan MA, Dixit K, Jabeen S, Moinuddin, Alam K. Impact of peroxynitrite modification on structure and immunogenicity of H2A histone. Scand J Immunol 69: 99-109, 2009.
54. Kim GH, Ryan JJ, Marsboom G, Archer SL. Epi-genetic mechanisms of pulmonary hypertension. Pulm Circ 1: 347-356, 2011.
55. Koch MW, Metz LM, Kovalchuk O. Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis. Trends Mol Med 19: 23-30, 2013.
56. Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 39: D152-D157, 2011.
57. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689, 2005.
58. Kumar M, Ahmad T, Sharma A, Mabalirajan U, Kulshreshtha A, Agrawal A, Ghosh B. Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immunol 128: 1077-1085, 2011.
59. Li G, Reinberg D. Chromatin higher-order structures and gene regulation. Curr Opin Genet Dev 21: 175-186, 2011.
60. Li M, Riddle SR, Frid MG, El Kasmi KC, McKinsey TA, Sokol RJ, Strassheim D, Meyrick B, Yeager ME, Flock-ton AR, McKeon BA, Lemon DD, Horn TR, Anwar A, Barajas C, Stenmark KR. Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. J Immunol 187: 2711-2722, 2011.
61. Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, Lee CW, Hu D, Lian BQ, Kleffel S, Yang Y, Neiswender J, Khorasani AJ, Fang R, Lezcano C, Duncan LM, Scolyer RA, Thompson JF, Kakavand H, Houvras Y, Zon LI, Mihm MC Jr, Kaiser UB, Schatton T, Woda BA, Murphy GF, Shi YG. Loss of 5-hydroxymethylcy-tosine is an epigenetic hallmark of melanoma. Cell 150: 1135-1146, 2012.
62. Lino Cardenas CL, Henaoui IS, Courcot E, Roder-burg C, Cauffiez C, Aubert S, Copin MC, Wallaert B, Glowacki F, Dewaeles E, Milosevic J, Maurizio J, Tedrow J, Marcet B, Lo-Guidice JM, Kaminski N, Barbry P, Luedde T, Perrais M, Mari B, Pottier N. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLos Genet 9: e1003291, 2013.
63. Liu G, Friggeri A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminski N, Abraham E. miR-21 mediates fibrogenic activation of pulmonary fi-broblasts and lung fibrosis. J Exp Med 207: 1589-1597, 2010.
64. Londhe VA, Sundar IK, Lopez B, Maisonet TM, Yu Y, Aghai ZH, Rahman I. Hyperoxia impairs alveolar formation and induces senescence through decreased histone deacetylase activity and up-regulation of p21 in neonatal mouse lung. Pediatr Res 69: 371-377, 2011.
65. Lu J, Qian J, Chen F, Tang X, Li C, Cardoso WV. Differential expression of components of the microRNA machinery during mouse organogen-esis. Biochem Biophys Res Commun 334: 319-323, 2005.
66. Lu Y, Thomson JM, Wong HY, Hammond SM, Hogan BL. Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 310: 442-453, 2007.
67. Luger K, Dechassa ML, Tremethick DJ. New insights into nucleosome and chromatin structure: an ordered state or a disordered affair? Nat Rev Mol Cell Biol 13: 436-447, 2012.
68. Meloche J, Paulin R, Provencher S, Bonnet S. Therapeutic Potential of microRNA modulation in pulmonary arterial hypertension. Curr Vasc Pharmacol. In press.
69. Meneghin A, Choi ES, Evanoff HL, Kunkel SL, Martinez FJ, Flaherty KR, Toews GB, Hogaboam CM. TLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiation. Histochem Cell Biol 130: 979-992, 2008.
70. Milosevic J, Pandit K, Magister M, Rabinovich E, Ellwanger DC, Yu G, Vuga LJ, Weksler B, Benos PV, Gibson KF, McMillan M, Kahn M, Kaminski N. Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol 47: 879-887, 2012.
71. Minagawa S, Araya J, Numata T, Nojiri S, Hara H, Yumino Y, Kawaishi M, Odaka M, Morikawa T, Nishimura SL, Nakayama K, Kuwano K. Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-beta-induced senescence of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 300: L391-L401, 2011.
72. Nana-Sinkam SP, Hunter MG, Nuovo GJ, Schmit-tgen TD, Gelinas R, Galas D, Marsh CB. Integrating the MicroRNome into the study of lung disease. Am J Respir Crit Care Med 179: 4-10, 2009.
73. Oak SR, Murray L, Herath A, Sleeman M, Anderson I, Joshi AD, Coelho AL, Flaherty KR, Toews GB, Knight D, Martinez FJ, Hogaboam CM. A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLos One 6: e21253, 2011.
74. Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Konishi K, Yousem SA, Singh M, Handley D, Richards T, Selman M, Wat-kins SC, Pardo A, Ben-Yehudah A, Bouros D, Eickelberg O, Ray P, Benos PV, Kaminski N. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182: 220-229, 2010.
75. Pandit KV, Milosevic J, Kaminski N. MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 157: 191-199, 2011.
76. Pang M, Zhuang S. Histone deacetylase: a potential therapeutic target for fibrotic disorders. J Pharmacol Exp Ther 335: 266-272, 2010.
77. Pfeifer GP, Rauch TA. DNA methylation patterns in lung carcinomas. Semin Cancer Biol 19: 181-187, 2009.
78. Pottier N, Maurin T, Chevalier B, Puissegur MP, Lebrigand K, Robbe-Sermesant K, Bertero T, Lino Cardenas CL, Courcot E, Rios G, Fourre S, Lo-Guidice JM, Marcet B, Cardinaud B, Barbry P, Mari B. Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibro-blasts: implication in epithelial-mesenchymal interactions. PLos One 4: e6718, 2009.
79. Qiu W, Baccarelli A, Carey VJ, Boutaoui N, Bacherman H, Klanderman B, Rennard S, Agusti A, Anderson W, Lomas DA, DeMeo DL. Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. Am J Respir Crit Care Med 185: 373-381, 2012.
80. Rabinovich EI, Kapetanaki MG, Steinfeld I, Gibson KF, Pandit KV, Yu G, Yakhini Z, Kaminski N. Global methylation patterns in idiopathic pulmonary fibrosis. PLos One 7: e33770, 2012.
81. Rexhaj E, Bloch J, Jayet PY, Rimoldi SF, Dessen P, Mathieu C, Tolsa JF, Nicod P, Scherrer U, Sartori C. Fetal programming of pulmonary vascular dysfunction in mice: role of epigenetic mechanisms. Am J Physiol Heart Circ Physiol 301: H247-H252, 2011.
82. Robinson CM, Neary R, Levendale A, Watson CJ, Baugh JA. Hypoxia-induced DNA hypermethyl-ation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotype. Respir Res 13: 74, 2012.
83. Salam MT, Zhang Y, Begum K. Epigenetics and childhood asthma: current evidence and future research directions. Epigenomics 4: 415-429, 2012.
84. Sanders YY, Ambalavanan N, Halloran B, Zhang X, Liu H, Crossman DK, Bray M, Zhang K, Than-nickal VJ, Hagood JS. Altered DNA Methylation Profile in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 186: 525-535, 2012.
85. Sanders YY, Cisneros J, Nuovo G, Selman M, Hagood JS. Epigenetic regulation mediates thy-1 gene silencing and induction of the myofibro-blast phenotype. Proc Am Thorac Soc 5: 363-364, 2008.
86. Sanders YY, Pardo A, Selman M, Nuovo GJ, Tollefsbol TO, Siegal GP, Hagood JS. Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. Am J Respir Cell Mol Biol 39: 610-618, 2008.
87. Sanders YY, Tollefsbol TO, Varisco BM, Hagood JS. Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. Am J Respir Cell Mol Biol 45: 16-23, 2011.
88. Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 100: 13225-13230, 2003.
89. Stenvang J, Petri A, Lindow M, Obad S, Kauppi-nen S. Inhibition of microRNA function by anti-miR oligonucleotides. Silence 3: 1, 2012.
90. Sun X, He Y, Huang C, Ma TT, Li J. The epigenetic feedback loop between DNA methylation and microRNAs in fibrotic disease with an emphasis on DNA methyltransferases. Cell Signal 25: 1870-1876, 2013.
91. Sundar IK, Yao H, Rahman I. Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases. Antioxid Redox Signal 18: 1956-1971, 2013.
92. Tahiliani M, Koh KP, Shen Y, Pastor WA, Banduk-wala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324: 930-935, 2009.
93. Tang X, Peng R, Phillips JE, Deguzman J, Ren Y, Apparsundaram S, Luo R, Bauer CM, Fuentes ME, Demartino JA, Tyagi G, Garrido R, Hoga-boam CM, Denton CP, Holmes AM, Kitson C, Stevenson CS, Budd DC. Assessment of Brd4 inhibition in idiopathic pulmonary fibrosis lung fibroblasts and in vivo models of lung fibrosis. Am J Pathol 183: 470-479, 2013.
94. Tang X, Peng R, Ren Y, Apparsundaram S, Deguzman J, Bauer CM, Hoffman AF, Hamilton S, Liang Z, Zeng H, Fuentes ME, Demartino JA, Kitson C, Stevenson CS, Budd DC. BET bro-modomain proteins mediate downstream signaling events following growth factor stimulation in human lung fibroblasts and are involved in bleo-mycin-induced pulmonary fibrosis. Mol Pharmacol 83: 283-293, 2013.
95. To M, Yamamura S, Akashi K, Charron CE, Barnes PJ, Ito K. Defect of adaptation to hyp-oxia in patients with COPD due to reduction of histone deacetylase 7. Chest 141: 1233-1242, 2012.
96. van Rooij E. The art of microRNA research. Circ Res 108: 219-234, 2011.
97. van Rooij E, Purcell AL, Levin AA. Developing microRNA therapeutics. Circ Res 110: 496-507, 2012.
98. Ventura A, Young AG, Winslow MM, Lintault L, Meissner A, Erkeland SJ, Newman J, Bronson RT, Crowley D, Stone JR, Jaenisch R, Sharp PA, Jacks T. Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132: 875-886, 2008.
99. Wan ES, Qiu W, Baccarelli A, Carey VJ, Bach-erman H, Rennard SI, Agusti A, Anderson WH, Lomas DA, DeMeo DL. Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186: 1248-1255, 2012.
100. 6-methyl-adenine: an epi-genetic signal for DNA-protein interactions. Nature Rev Microbiol 4: 183-192, 2006.
101. Wright DE, Wang CY, Kao CF. Histone ubiquity-lation and chromatin dynamics. Front Biosci 17: 1051-1078, 2012.
102. Wu X, Chang MS, Mitsialis SA, Kourembanas S. Hypoxia regulates bone morphogenetic protein signaling through C-terminal-binding protein 1. Circ Res 99: 240-247, 2006.
103. Wynn TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 208: 1339-1350, 2011.
104. Xi Q, He W, Zhang XH, Le HV, Massague J. Genome-wide impact of the BRG1 SWI/SNF chromatin remodeler on the transforming growth factor beta transcriptional program. J Biol Chem 283: 1146-1155, 2008.
105. Yang Q, Lu Z, Singh D, Raj JU. BIX-01294 treatment blocks cell proliferation, migration and contractility in ovine foetal pulmonary arterial smooth muscle cells. Cell Prolif 45: 335-344, 2012.
106. Yang S, Banerjee S, de Freitas A, Sanders YY, Ding Q, Matalon S, Thannickal VJ, Abraham E, Liu G. Participation of miR-200 in pulmonary fibrosis. Am J Pathol 180: 484-493, 2012.
107. Yang S, Cui H, Xie N, Icyuz M, Banerjee S, Antony VB, Abraham E, Thannickal VJ, Liu G. miR-145 regulates myofibroblast differentiation and lung fibrosis. FASEB J 27: 2382-2391, 2013.
108. Yao H, Rahman I. Role of histone deacetylase 2 in epigenetics and cellular senescence: implications in lung inflammaging and COPD. Am J Physiol Lung Cell Mol Physiol 303: L557-L566, 2012.
109. Zhai Y, Zhong Z, Chen CY, Xia Z, Song L, Blackburn MR, Shyu AB. Coordinated changes in mRNA turnover, translation, and RNA processing bodies in bronchial epithelial cells following inflammatory stimulation. Mol Cell Biol 28: 7414-7426, 2008.
110. Zhao L, Chen CN, Hajji N, Oliver E, Cotroneo E, Wharton J, Wang D, Li M, McKinsey TA, Sten-mark KR, Wilkins MR. Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoy-lanilide hydroxamic acid. Circulation 126: 455-467, 2012.
111. Ziller MJ, Muller F, Liao J, Zhang Y, Gu H, Bock C, Boyle P, Epstein CB, Bernstein BE, Lengauer T, Gnirke A, Meissner A. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLos Genet 7: e1002389, 2011.